A case of adult onset pure pallidal degeneration. II. Analysis of neurotransmitter markers, with special reference to the termination of pallidothalamic tract in human brain.
We analyzed neurotransmitter markers in a brain of a very rare case of pathologically confirmed adult-onset pure pallidal degeneration (PPD) as compared with 16 controls. Neurotransmitter concentrations are significantly altered in the globus pallidus (GP), subthalamic nucleus (ST) and the thalamic nuclei. Concentrations of gamma-aminobutyric acid (GABA) in the external segment (GPe) and internal segment (GPi) of GP and ST are decreased to 62, 45 and 55% of the control mean, respectively. Concentrations of glutamic acid are increased in GPi (144%) and ST (134%). Choline acetyltransferase (ChAT) activities are increased in GPe (232%), GPi (218%), ST (161%), and ventroanterior (VA, 210%) and ventrolateral nucleus (VL, 193%) of the thalamus. Noradrenaline (NA) concentrations in GPe and GPi are 56 and 43% of the control mean, respectively. Dopaminergic and serotonergic systems show no remarkable change. The grid microdissection analysis demonstrates a patchy GABA distribution in the thalamus of 3 controls, whereas a small GABA-rich area in the ventro-oral nucleus (VO) according to the atlas of Hopf disappears in adult onset PPD. These results strongly suggest that (1) GP GABAergic neurons are selectively degenerated and striatopallidal GABAergic nerve terminals are hypoactive; (2) ChAT activities in GP, ST, VA and VL are increased; (3) the subthalamopallidal glutamatergic system is not hypoactive; (4) activity of the noradrenergic system in GP is decreased; and that (5) VO in the thalamus specifically receives GABAergic nerve terminals from GP in human brain.
National Institute of Neuroscience, National Center of Neurology and Psychiatry, Tokyo, Japan.
H
H
Aizawa
S
S
Kwak
T
T
Shimizu
T
T
Mannen
H
H
Shibasaki
D000328:Adult; D000368:Aged; D001480:Basal Ganglia Diseases / Q000150:complications / Q000378:metabolism* / Q000473:pathology; D015415:Biomarkers; D001923:Brain Chemistry; D002795:Choline O-Acetyltransferase / Q000032:analysis; D005260:Female; D005917:Globus Pallidus / Q000737:chemistry* / Q000473:pathology; D005971:Glutamates / Q000032:analysis; D018698:Glutamic Acid; D006801:Humans; D008297:Male; D008875:Middle Aged; D009069:Movement Disorders / Q000209:etiology / Q000378:metabolism* / Q000473:pathology; D009410:Nerve Degeneration; D018377:Neurotransmitter Agents / Q000032:analysis*; D009638:Norepinephrine / Q000032:analysis; D013788:Thalamus / Q000737:chemistry* / Q000473:pathology; D005680:gamma-Aminobutyric Acid / Q000032:analysis
D015415:Biomarkers; D005971:Glutamates; D018377:Neurotransmitter Agents; D018698:Glutamic Acid; D005680:gamma-Aminobutyric Acid; D002795:Choline O-Acetyltransferase; D009638:Norepinephrine